Please Login to read the full article.
Clinica
Bard splashes out $250m on hypothermia firm Medivance; spending cuts help Q3 growth
26 October 2011
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Bard strengthens vascular offering with $69m ClearStream acquisition
- Quarterly results round-up: LabCorp, Bard hit by legal costs; Edwards, Intuitive grow top and bottom lines
- Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
Other Informa News
EVENTS
